| Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma L Zhang, Y Yao, S Zhang, Y Liu, H Guo, M Ahmed, T Bell, H Zhang, G Han, ... Science translational medicine 11 (491), eaau1167, 2019 | 207 | 2019 |
| Long non-coding RNA SNHG5 suppresses gastric cancer progression by trapping MTA2 in the cytosol L Zhao, H Guo, B Zhou, J Feng, Y Li, T Han, L Liu, L Li, S Zhang, Y Liu, ... Oncogene 35 (44), 5770-5780, 2016 | 127 | 2016 |
| A double feedback loop mediated by microRNA-23a/27a/24-2 regulates M1 versus M2 macrophage polarization and thus regulates cancer progression S Ma, M Liu, Z Xu, Y Li, H Guo, Y Ge, Y Liu, D Zheng, J Shi Oncotarget 7 (12), 13502, 2016 | 112 | 2016 |
| Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma J Lee, LL Zhang, W Wu, H Guo, Y Li, M Sukhanova, G Venkataraman, ... Blood Advances 2 (16), 2039-2051, 2018 | 59 | 2018 |
| PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K/AKT in lymphoma cells F Zhu, H Guo, PD Bates, S Zhang, H Zhang, KJ Nomie, Y Li, L Lu, ... Leukemia 33 (12), 2898-2911, 2019 | 56 | 2019 |
| B-cell lymphoma patient-derived xenograft models enable drug discovery and are a platform for personalized therapy L Zhang, K Nomie, H Zhang, T Bell, L Pham, S Kadri, J Segal, S Li, ... Clinical Cancer Research 23 (15), 4212-4223, 2017 | 55 | 2017 |
| GALNT5 uaRNA promotes gastric cancer progression through its interaction with HSP90 H Guo, L Zhao, B Shi, J Bao, D Zheng, B Zhou, J Shi Oncogene 37 (33), 4505-4517, 2018 | 39 | 2018 |
| RIP1 modulates death receptor mediated apoptosis and autophagy in macrophages Z Yao, P Zhang, H Guo, J Shi, S Liu, Y Liu, D Zheng Molecular oncology 9 (4), 806-817, 2015 | 29 | 2015 |
| Pleiotropic action of novel Bruton's tyrosine kinase inhibitor BGB-3111 in mantle cell lymphoma CJ Li, C Jiang, Y Liu, T Bell, W Ma, Y Ye, S Huang, H Guo, H Zhang, ... Molecular cancer therapeutics 18 (2), 267-277, 2019 | 28 | 2019 |
| Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma H Guo, D Zeng, H Zhang, T Bell, J Yao, Y Liu, S Huang, CJ Li, E Lorence, ... Oncogene 38 (11), 1802-1814, 2019 | 23 | 2019 |
| Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma J Wang, J Wang, E Lopez, H Guo, H Zhang, Y Liu, Z Chen, S Huang, ... Blood cancer journal 9 (12), 95, 2019 | 22 | 2019 |
| The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma S Huang, C Jiang, H Zhang, T Bell, H Guo, Y Liu, Y Yao, D Zeng, ... Blood cancer journal 8 (3), 33, 2018 | 22 | 2018 |
| Specificity protein 1 regulates topoisomerase IIβ expression in SH‐SY5Y cells during neuronal differentiation H Guo, C Cao, X Chi, J Zhao, X Liu, N Zhou, S Han, Y Yan, Y Wang, Y Xu, ... Journal of neuroscience research 92 (10), 1374-1383, 2014 | 19 | 2014 |
| Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2 W Wu, W Wang, CA Franzen, H Guo, J Lee, Y Li, M Sukhanova, D Sheng, ... Blood Advances 5 (1), 185-197, 2021 | 12 | 2021 |
| The effects of PI3K-δ/γ inhibitor, duvelisib, in mantle cell lymphoma in vitro and in patient-derived xenograft studies J Wang, V Zhang, T Bell, Y Liu, H Guo, L Zhang Blood, The Journal of the American Society of Hematology 128 (22), 3016-3016, 2016 | 11 | 2016 |
| Resistance mechanisms underlying venetoclax resistance in mantle cell lymphoma S Huang, C Jiang, H Guo, J Wang, Y Liu, C Li, E Lopez, H Zhang, ... Blood 130, 2749, 2017 | 8 | 2017 |
| Pre-clinical evaluation of the PI3K-p110β/δ inhibitor KA2237 in mantle cell lymphoma S Huang, LJ Nastoupil, H Guo, T Bell, M Ahmed, CJ Li, J Wang, Y Liu, ... Blood, The Journal of the American Society of Hematology 128 (22), 1837-1837, 2016 | 5 | 2016 |
| Novel Bruton's Tyrosine Kinase Inhibitor Bgb-3111 Demonstrates Potent Activity in Mantle Cell Lymphoma CJ Li, Y Liu, T Bell, J Wang, H Guo, M Ahmed, H Zhang, LT Lam, K Nomie, ... Blood, The Journal of the American Society of Hematology 128 (22), 5374-5374, 2016 | 4 | 2016 |
| Genetic and molecular characterization of ibrutinib-resistant mantle cell lymphoma: designing innovative therapeutic strategies H Guo, S Huang, Y Liu, CJ Li, J Wang, V Zhang, M Ahmed, LT Lam, ... Blood 128 (22), 1838, 2016 | 4 | 2016 |
| Genetically defined metabolic targets overcome ibrutinib resistance in mantle cell lymphoma L Zhang, H Guo, H Zhang, Y Yao, Y Liu, S Zhang, L Rui, L Wang, K Nomie, ... Blood 134, 395, 2019 | 3 | 2019 |
